Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) EBIT (2017 - 2025)

Historic EBIT for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to -$296960.0.

  • Selectis Health's EBIT rose 7465.7% to -$296960.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 million, marking a year-over-year increase of 7748.98%. This contributed to the annual value of -$2.7 million for FY2024, which is 6954.16% up from last year.
  • Per Selectis Health's latest filing, its EBIT stood at -$296960.0 for Q3 2025, which was up 7465.7% from -$450289.0 recorded in Q2 2025.
  • In the past 5 years, Selectis Health's EBIT ranged from a high of $1.3 million in Q2 2022 and a low of -$3.0 million during Q4 2023
  • In the last 5 years, Selectis Health's EBIT had a median value of -$450289.0 in 2025 and averaged -$705519.8.
  • Its EBIT has fluctuated over the past 5 years, first tumbled by 79065.7% in 2021, then skyrocketed by 6396451.77% in 2022.
  • Selectis Health's EBIT (Quarter) stood at -$1.2 million in 2021, then dropped by 23.25% to -$1.4 million in 2022, then crashed by 108.95% to -$3.0 million in 2023, then skyrocketed by 96.75% to -$97261.0 in 2024, then plummeted by 205.32% to -$296960.0 in 2025.
  • Its EBIT was -$296960.0 in Q3 2025, compared to -$450289.0 in Q2 2025 and -$421746.0 in Q1 2025.